SIJSS: Does the iFuse Procedure work? (Peter Whang, MD) | SI-BONE
To find out how SI-BONE is dealing with COVID-19, please CLICK HERE

Resource Library for Healthcare Providers

SIJSS: Does the iFuse Procedure work? (Peter Whang, MD)

This presentation was recorded during the 4th SI Joint Surgery Society (SIJSS) Meeting 2014 - iFuse Surgeon User Group.

Peter Whang, MD* presents clinical study results of the iFuse Procedure.

Outline

  • SI Joint Pathology – Burden of Disease
  • Clinical Trials Overview – SIFI, INSITE, iMIA
  • Clinical Evidence


*Peter Whang, MD is a paid consultant and clinical trial investigator for SI-BONE, Inc.

The iFuse Implant System is intended for sacroiliac fusion for conditions including sacroiliac joint dysfunction that is a direct result of sacroiliac joint disruption and degenerative sacroiliitis. This includes conditions whose symptoms began during pregnancy or in the peripartum period and have persisted postpartum for more than 6 months. There are potential risks associated with the iFuse Implant System. It may not be appropriate for all patients and all patients may not benefit. For information about the risks, visit: www.si-bone.com/risks

Find a Doctor

Looking for Answers?

We can help. Tell us what you're looking for below.